Cue Biopharma, Inc.
CUE
←Back to Recent Filings
| Filing |
DATE |
FP |
FY |
End Date |
URL |
VIEW |
|
| 8-K |
11/12/2025 |
Q3 |
2025 |
9/30/2025 |
SEC |
view |
data |
| 10-Q |
11/12/2025 |
Q3 |
2025 |
9/30/2025 |
SEC |
view |
|
| 8-K |
8/12/2025 |
Q2 |
2025 |
6/30/2025 |
SEC |
view |
data |
| 10-Q |
8/12/2025 |
Q2 |
2025 |
6/30/2025 |
SEC |
view |
|
| 8-K |
5/12/2025 |
Q1 |
2025 |
3/31/2025 |
SEC |
view |
data |
| 10-Q |
5/12/2025 |
Q1 |
2025 |
3/31/2025 |
SEC |
view |
|
| 8-K |
3/31/2025 |
Q4 |
2024 |
12/31/2024 |
SEC |
view |
data |
| 10-K |
3/31/2025 |
Q4 |
2024 |
12/31/2024 |
SEC |
view |
|
| 8-K |
11/14/2024 |
Q3 |
2024 |
9/30/2024 |
SEC |
view |
data |
| 10-Q |
11/14/2024 |
Q3 |
2024 |
9/30/2024 |
SEC |
view |
|
| WIREPR |
8/19/2024 |
Q2 |
2024 |
6/30/2024 |
WIRE |
view |
data |
| 10-Q |
8/14/2024 |
Q2 |
2024 |
6/30/2024 |
SEC |
view |
|
| 8-K |
5/9/2024 |
Q1 |
2024 |
3/31/2024 |
SEC |
view |
data |
| 10-Q |
5/9/2024 |
Q1 |
2024 |
3/31/2024 |
SEC |
view |
|
| WIREPR |
4/8/2024 |
Q1 |
2024 |
3/31/2024 |
WIRE |
view |
data |
| 10-K |
3/28/2024 |
Q4 |
2023 |
12/31/2023 |
SEC |
view |
|
| WIREPR |
11/9/2023 |
Q3 |
2023 |
9/30/2023 |
WIRE |
view |
data |
| 10-Q |
11/3/2023 |
Q3 |
2023 |
9/30/2023 |
SEC |
view |
|
| WIREPR |
8/9/2023 |
Q2 |
2023 |
6/30/2023 |
WIRE |
view |
data |
| 10-Q |
8/8/2023 |
Q2 |
2023 |
6/30/2023 |
SEC |
view |
|
| WIREPR |
5/9/2023 |
Q1 |
2023 |
3/31/2023 |
WIRE |
view |
data |
| 10-Q |
5/9/2023 |
Q1 |
2023 |
3/31/2023 |
SEC |
view |
|
| WIREPR |
3/21/2023 |
Q4 |
2022 |
12/31/2022 |
WIRE |
view |
data |
| 10-K |
3/21/2023 |
Q4 |
2022 |
12/31/2022 |
SEC |
view |
|
| WIREPR |
11/14/2022 |
Q3 |
2022 |
9/30/2022 |
WIRE |
view |
data |
| 10-Q |
11/14/2022 |
Q3 |
2022 |
9/30/2022 |
SEC |
view |
|
| WIREPR |
8/4/2022 |
Q2 |
2022 |
6/30/2022 |
WIRE |
view |
data |
| 10-Q |
8/4/2022 |
Q2 |
2022 |
6/30/2022 |
SEC |
view |
|
| WIREPR |
5/10/2022 |
Q1 |
2022 |
3/31/2022 |
WIRE |
view |
data |
| 10-Q |
5/10/2022 |
Q1 |
2022 |
3/31/2022 |
SEC |
view |
|
| 10-K |
3/16/2022 |
Q4 |
2021 |
12/31/2021 |
SEC |
view |
|
| 10-Q |
11/9/2021 |
Q3 |
2021 |
9/30/2021 |
SEC |
view |
|
| WIREPR |
8/17/2021 |
Q2 |
2021 |
6/30/2021 |
WIRE |
view |
data |
| 10-Q |
8/9/2021 |
Q2 |
2021 |
6/30/2021 |
SEC |
view |
|
| WIREPR |
5/17/2021 |
Q1 |
2021 |
3/31/2021 |
WIRE |
view |
data |
| 10-Q |
5/10/2021 |
Q1 |
2021 |
3/31/2021 |
SEC |
view |
|
| WIREPR |
3/16/2021 |
Q4 |
2020 |
12/31/2020 |
WIRE |
view |
data |
| 10-K |
3/9/2021 |
Q4 |
2020 |
12/31/2020 |
SEC |
view |
|
| WIREPR |
11/17/2020 |
Q3 |
2020 |
9/30/2020 |
WIRE |
view |
data |
| 10-Q |
11/9/2020 |
Q3 |
2020 |
9/30/2020 |
SEC |
view |
|
| WIREPR |
8/31/2020 |
Q2 |
2020 |
6/30/2020 |
WIRE |
view |
data |
| 10-Q |
8/10/2020 |
Q2 |
2020 |
6/30/2020 |
SEC |
view |
|
| 8-K |
5/19/2020 |
Q1 |
2020 |
3/31/2020 |
SEC |
view |
data |
| 10-Q |
5/7/2020 |
Q1 |
2020 |
3/31/2020 |
SEC |
view |
|
| 8-K |
3/17/2020 |
Q4 |
2019 |
12/31/2019 |
SEC |
view |
data |
| 10-K |
3/12/2020 |
Q4 |
2019 |
12/31/2019 |
SEC |
view |
|
| 8-K |
11/12/2019 |
Q3 |
2019 |
9/30/2019 |
SEC |
view |
data |
| 10-Q |
11/7/2019 |
Q3 |
2019 |
9/30/2019 |
SEC |
view |
|
| 10-Q |
8/8/2019 |
Q2 |
2019 |
6/30/2019 |
SEC |
view |
|
| 10-Q/A [Amend] |
7/9/2019 |
Q1 |
2019 |
3/31/2019 |
SEC |
view |
|
| 10-K/A [Amend] |
7/9/2019 |
Q4 |
2018 |
12/31/2018 |
SEC |
view |
|
| 10-Q |
5/8/2019 |
Q1 |
2019 |
3/31/2019 |
SEC |
view |
|
| 10-K/A [Amend] |
4/30/2019 |
Q4 |
2018 |
12/31/2018 |
SEC |
view |
|
| 10-K |
3/14/2019 |
Q4 |
2018 |
12/31/2018 |
SEC |
view |
|
| 10-Q |
11/13/2018 |
Q3 |
2018 |
9/30/2018 |
SEC |
view |
|
| 10-Q |
8/13/2018 |
Q2 |
2018 |
6/30/2018 |
SEC |
view |
|
| 10-Q |
5/14/2018 |
Q1 |
2018 |
3/31/2018 |
SEC |
view |
|
| 10-K |
3/29/2018 |
Q4 |
2017 |
12/31/2017 |
SEC |
view |
|